Clindamycin is a lincosamide antibiotic. It is usually used to treat infections with anaerobic bacteria, but can also be used to treat some protozoal diseases, such as malaria. It is a common topical treatment for acne and can be useful against some methicillin-resistant Staphylococcus aureus (MRSA) infections.[1] The most severe common adverse effect of clindamycin is Clostridium difficile-associated diarrhea (the most frequent cause of pseudomembranous colitis). Although this side effect occurs with almost all antibiotics, including beta-lactam antibiotics, it is classically linked to clindamycin use.[2]

Synonyms:
(7S)-7-Chloro-7-deoxylincomycin hydrochloride; (2S-trans)-Methyl 7-Chloro-6,7,8-trideoxy-6[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-L-threo-a-D-galacto-octopyranoside

CAS No:
21462-39-5

Molecular Formula:
C18H34Cl2N2O5S

Molecular Weight:
461.44

Appearance:
Supplied as a white powder.

Potency:
≥860ug/mg

Water:
≤5%

Storage and Stability:
Powder may be stored at -20°C. Stable for 6 months at -20°C. Hygroscopic. Store under inert atmosphere.